Decellularized extracellular matrix-based scaffold and hypoxic priming: A promising combination to improve the phenotype of degenerate intervertebral disc cells.


Journal

Life sciences
ISSN: 1879-0631
Titre abrégé: Life Sci
Pays: Netherlands
ID NLM: 0375521

Informations de publication

Date de publication:
15 Jul 2022
Historique:
received: 25 01 2022
revised: 27 04 2022
accepted: 05 05 2022
pubmed: 11 5 2022
medline: 7 6 2022
entrez: 10 5 2022
Statut: ppublish

Résumé

The main cause of low back pain is the intervertebral disc (IVD) degeneration. Designing an effective disc regeneration strategy still remains a major challenge, especially for the lack of effective self-healing capacity. Understanding the properties of IVD cells in the degenerate microenvironment could help to develop in situ regeneration strategies. The objective of the present study was to investigate the ability of degenerate cells to respond to conditions they experience physiologically in their niche in vivo, namely the presence of the hypoxic environment and trophic factors. Degenerate cells from IVD of patients operated for herniated disc were exposed to hypoxic priming and decellularized Wharton's jelly matrix (DWJM) as scaffold and trophic factors source for 48 h in culture. Cell response was evaluated in terms of cell viability, proliferation, cytoskeletal organization, migratory ability and expression of discogenic transcription factors (SOX9, TRPS1), hypoxia-inducible factor 1α (HIF-1α) and longevity transcription factor FOXO3a. The recruitment of HIF-1α at FOXO3a and SOX9 gene promoters was analyzed by Chromatin immunoprecipitation. Degenerate IVD cells were able to re-acquire the discogenic phenotype, and to re-adapt to hypoxia after exposure to hypoxic priming and DWJM. We demonstrated for the first time that HIF-1α is specifically recruited at the promoter of SOX9 and FOXO3a which are crucial for IVD homeostasis and repair. These results open new avenues to engineer IVD by demonstrating that appropriate stimuli are able to dampen the degenerated IVD cell phenotype and to promote anabolic activity in cells which are constitutively characterized by poor reparative capacity.

Identifiants

pubmed: 35537547
pii: S0024-3205(22)00323-X
doi: 10.1016/j.lfs.2022.120623
pii:
doi:

Substances chimiques

Decellularized Extracellular Matrix 0
Repressor Proteins 0
TRPS1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

120623

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Letizia Penolazzi (L)

Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.

Elisabetta Lambertini (E)

Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.

Stefania D'Agostino (S)

Stem Cells and Regenerative Medicine Lab, Fondazione Istituto di Ricerca Pediatrica Città della Speranza, 35129 Padua, Italy; Department of Women's and Children's Health, University of Padova, 35127 Padua, Italy.

Michela Pozzobon (M)

Stem Cells and Regenerative Medicine Lab, Fondazione Istituto di Ricerca Pediatrica Città della Speranza, 35129 Padua, Italy; Department of Women's and Children's Health, University of Padova, 35127 Padua, Italy.

Maria Pina Notarangelo (MP)

Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.

Pantaleo Greco (P)

Department of Medical Sciences, Obstetrics and Gynecology Unit, Sant'Anna University Hospital, 44121 Ferrara, Italy.

Pasquale De Bonis (P)

Department of Translational Medicine, Neurosurgery Department, Sant'Anna University Hospital, 44121 Ferrara, Italy.

Claudio Nastruzzi (C)

Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, 44121 Ferrara, Italy.

Roberta Piva (R)

Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy. Electronic address: piv@unife.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH